Unleashing the Scoop: Perma-Fix Environmental Services Inc.’s Q3 2024 Earnings Call Recap

Perma-Fix Environmental Services, Inc. (NASDAQ:PESI) Q3 2024 Earnings Conference Call Company Participants David Waldman – Investor Relations Mark Duff – President and Chief Executive Officer Louis Centofanti – Executive Vice President of Strategic Initiatives Ben Naccarato – Executive Vice President and Chief Financial Officer Conference Call Participants Howard Brous – Wellington Shields & Co. Aaron…

Read More

“Unpacking TRON’s Latest Move: Justin Sun Spills the Tea on Trump’s WBTC Bitcoin Reserves”

Tron Founder Justin Sun’s Insights on World Liberty Financial’s Massive Investments in Wrapped Bitcoin By: Your Name August 12, 2021 Well, well, well, folks! It looks like the crypto world just got a little bit more interesting today. Just when you thought things couldn’t get any crazier, Tron founder Justin Sun has dropped some major…

Read More

Carbon Emission Reductions Just Got a Boost: Carnrite and Persefoni Team Up to Tackle Climate Change!

Witty Innovation: Carnrite Group and Persefoni Inc. Collaborate on Footprint Solution It’s not every day that you hear about two powerhouses in the energy and sustainability sector teaming up for a groundbreaking project. But that’s exactly what Carnrite Group and Persefoni Inc. have done with their recent announcement of a new Footprint Solution. The news,…

Read More

Record High: XRP Ledger’s Native Token Surpasses $29.5 Billion in Largest Whale Holdings – A Heartfelt Milestone for XRP Community

The Rise of XRP Token Accumulation Deep-pocketed holders of the XRP Ledger (XRPL) native token are rapidly accumulating the digital asset, according to blockchain analytics platform Santiment. Whales and sharks have been aggressively adding more XRP to their holdings during the past 11 months, reaching a record high of 51.59 billion tokens worth more than…

Read More

Akero Therapeutics Announces Planned Public Offering of Common Stock

Akero Therapeutics, Inc. Announces Public Offering South San Francisco, Calif., Jan. 27, 2025 Akero Therapeutics, Inc. (Nasdaq: AKRO) has announced the commencement of an underwritten public offering of $300.0 million of shares of its common stock. The clinical-stage company is focused on developing transformational treatments for patients with serious metabolic diseases characterized by high unmet…

Read More